Affinium Pharmaceuticals' Series B Round

Affinium Pharmaceuticals raised a round of funding on August 29, 2011.

Affinium Pharmaceuticals is a specialty pharmaceutical company developing a class of antibiotics that target the bacterial fatty acid synthesis (FASII) pathway. AFN-1252, the company's lead clinical c…

Articles about Affinium Pharmaceuticals' Series B Round: